PlainRecalls
FDA Drug Moderate Class II Terminated

Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDC 13668-0325-30 Repackaged NDC 70518-1220-00

Reported: October 31, 2018 Initiated: August 24, 2018 #D-0093-2019

Product Description

Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDC 13668-0325-30 Repackaged NDC 70518-1220-00

Reason for Recall

CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
2 bottles of 90 tablets (180 tablets)
Distribution
Product was distributed to a medical facility in South Carolina
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDC 13668-0325-30 Repackaged NDC 70518-1220-00. Recalled by RemedyRepack Inc.. Units affected: 2 bottles of 90 tablets (180 tablets).
Why was this product recalled?
CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 31, 2018. Severity: Moderate. Recall number: D-0093-2019.